Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Net Cash Flow (2016 - 2026)

Puma Biotechnology filings provide 9 years of Net Cash Flow readings, the most recent being -$23.9 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 1322.34% to -$23.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$39.6 million, a 157.62% decrease, with the full-year FY2025 number at -$39.6 million, down 157.62% from a year prior.
  • Net Cash Flow hit -$23.9 million in Q4 2025 for Puma Biotechnology, down from -$1.1 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $25.2 million in Q3 2022 to a low of -$25.9 million in Q3 2021.
  • Median Net Cash Flow over the past 5 years was -$3.8 million (2021), compared with a mean of -$3.3 million.
  • Biggest five-year swings in Net Cash Flow: tumbled 3078.04% in 2021 and later skyrocketed 229.9% in 2023.
  • Puma Biotechnology's Net Cash Flow stood at -$816000.0 in 2021, then plummeted by 115.56% to -$1.8 million in 2022, then skyrocketed by 229.9% to $2.3 million in 2023, then decreased by 14.4% to $2.0 million in 2024, then plummeted by 1322.34% to -$23.9 million in 2025.
  • The last three reported values for Net Cash Flow were -$23.9 million (Q4 2025), -$1.1 million (Q3 2025), and -$8.4 million (Q2 2025) per Business Quant data.